Taking the “unknown” out of CKDu—optimizing approaches to uncover the cause(s) of epidemic-level kidney disease in low- and middle-income settings: a report from the ISN’s International Consortium of CKDu Collaborators (ISN i3C)

Chronic kidney disease of undetermined etiology (CKDu) is a major cause of mortality that affects communities, health systems, and national economies. Despite 2 decades of descriptive and analytical research, the causes of CKDu epidemics remain unclear. In February 2025, at the World Congress of Nephrology, the International Society of Nephrology's International Consortium of CKDu Collaborators met to discuss the obstacles to determining the cause(s) of the epidemics. Several key themes were identified: First, differences in CKDu burden between regions are poorly described, and this is complicated by inconsistent terminology. Second, some proposed primary causes of CKDu are also progression factors in chronic kidney disease of all causes. It is unclear whether such factors can explain CKDu epidemics, partly because of the challenges around distinguishing disease onset from progression. Lastly, there is a need for alternatives to self-report in capturing exposures. This report outlines the current state of the field, describes these themes in more detail, and offers suggestions to optimize future research efforts.

Authors

Institutions

Publication Details

Journal
Kidney International
Published
2026-01-22
DOI
https://doi.org/10.1016/j.kint.2025.12.027
Citations
1
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
34.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Taking the “unknown” out of CKDu—optimizing approaches to uncover the cause(s) of epidemic-level kidney disease in low- and middle-income settings: a report from the ISN’s International Consortium of CKDu Collaborators (ISN i3C)

Anna Strasma, Swaminathan Sundar, Nathan H. Raines, Eranga Wijewickrama et al.
1 citations
Kidney International
Chronic Kidney Disease and Diabetes
34.94
article

Taking the “unknown” out of CKDu—optimizing approaches to uncover the cause(s) of epidemic-level kidney disease in low- and middle-income settings: a report from the ISN’s International Consortium of CKDu Collaborators (ISN i3C)

Anna Strasma, Swaminathan Sundar, Nathan H. Raines, Eranga Wijewickrama, Ben Caplin, S. Anand, Sundararaman Swaminathan, Sharan Murali, Manikanda Nesan S, Rebecca Fischer, Magdalena Madero, Sreejith Parameswaran, Adeera Levin, Nalika Guanwardena, Sushrut Waikar, Marie Michael, Priti Meena, Kristina Jakobsson, Ana Catalina Alvarez Elias, Marvin González Quiroz, Suman Behera, Namrata Rao
article en
1 citations

Abstract

Chronic kidney disease of undetermined etiology (CKDu) is a major cause of mortality that affects communities, health systems, and national economies. Despite 2 decades of descriptive and analytical research, the causes of CKDu epidemics remain unclear. In February 2025, at the World Congress of Nephrology, the International Society of Nephrology's International Consortium of CKDu Collaborators met to discuss the obstacles to determining the cause(s) of the epidemics. Several key themes were identified: First, differences in CKDu burden between regions are poorly described, and this is complicated by inconsistent terminology. Second, some proposed primary causes of CKDu are also progression factors in chronic kidney disease of all causes. It is unclear whether such factors can explain CKDu epidemics, partly because of the challenges around distinguishing disease onset from progression. Lastly, there is a need for alternatives to self-report in capturing exposures. This report outlines the current state of the field, describes these themes in more detail, and offers suggestions to optimize future research efforts.

Kidney InternationalVol. 109(4)
Boston University (US), The University of Texas at San Antonio Health Science Center (US), Duke University (US), Columbia University Irving Medical Center (US), Kidney Research UK (GB), Tata Medical Center (IN), Health Data Research UK (GB), Instituto Nacional de Cardiología (MX), University College London (GB), The University of Texas at San Antonio (US), University of Colombo (LK), Stanford University (US)
No poverty
Openalex Percentile: Top 1%
Chronic Kidney Disease and Diabetes
34.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.